Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats
- PMID: 21705971
- DOI: 10.1097/TP.0b013e3182241106
Both darbepoetin alfa and carbamylated erythropoietin prevent kidney graft dysfunction due to ischemia/reperfusion in rats
Abstract
Background: Ischemia/reperfusion (I/R) injury is an important cause of renal graft dysfunction. Increases in cold and warm ischemia times lead to a higher risk of early posttransplant complications including delayed graft function and acute rejection. Moreover, prolonged cold ischemia is a predictor of long-term graft loss in kidney transplant patients.
Methods: Darbepoetin alfa (DA) and carbamylated nonerythropoietic derivative of erythropoietin (CEPO) protective effects were evaluated in a model of I/R injury after kidney transplantation in both syngeneic and allogeneic combinations. The effects of wortmannin (phosphorylated Akt [p-Akt] inhibitor) administration were also investigated. Serum creatinine was evaluated at 16, 24, 48 hr and at 4 and 7 days posttransplant. Animals were killed 24 hr or 7 days after transplant and kidneys were processed for histological analysis, immunohistochemistry assessment of erythropoietin receptor (EPOR) and β-common chain receptor expression, granulocyte infiltration, nitrotyrosine staining, p-Akt expression, peritubular capillary (PTC) density, apoptosis, antioxidant, and antiapoptotic gene expression.
Results: DA and CEPO significantly reduced serum creatinine, tubular injury, tubular nitrotyrosine staining, and prevented I/R-induced tubular apoptosis, but only when given both to the donor and to the recipient. DA and CEPO cytoprotection was associated with prevention of I/R-induced drop of p-Akt expression in tubuli, and almost complete preservation of capillary density in the tubulointerstitium of the graft. CEPO was more effective than DA in reducing tubular oxidative stress and preserving PTCs.
Conclusion: DA and CEPO when given both to the donor and to the recipient, prevented renal graft dysfunction, tubular oxidative stress, and apoptosis after I/R injury in kidney transplantation. Their cytoprotection was mediated by tubular p-Akt activation and PTC density preservation.
Similar articles
-
Rabbit anti-rat thymocyte immunoglobulin preserves renal function during ischemia/reperfusion injury in rat kidney transplantation.Transpl Int. 2011 Aug;24(8):829-38. doi: 10.1111/j.1432-2277.2011.01263.x. Epub 2011 May 5. Transpl Int. 2011. PMID: 21545548
-
Supplemental hydrogen sulphide protects transplant kidney function and prolongs recipient survival after prolonged cold ischaemia-reperfusion injury by mitigating renal graft apoptosis and inflammation.BJU Int. 2012 Dec;110(11 Pt C):E1187-95. doi: 10.1111/j.1464-410X.2012.11526.x. Epub 2012 Nov 16. BJU Int. 2012. PMID: 23157304
-
Carbamylated erythropoietin protects the myocardium from acute ischemia/reperfusion injury through a PI3K/Akt-dependent mechanism.Surgery. 2009 Sep;146(3):506-14. doi: 10.1016/j.surg.2009.03.022. Epub 2009 Jun 9. Surgery. 2009. PMID: 19715808
-
[Kidney transplantation: how shall we deal with marginal cases? Future prospects from basic research].Hinyokika Kiyo. 2010 Aug;56(8):481-4. Hinyokika Kiyo. 2010. PMID: 20808071 Review. Japanese.
-
Biological modulation of renal ischemia-reperfusion injury.Curr Opin Organ Transplant. 2010 Apr;15(2):190-9. doi: 10.1097/MOT.0b013e32833593eb. Curr Opin Organ Transplant. 2010. PMID: 20009928 Review.
Cited by
-
ARA290, a non-erythropoietic EPO derivative, attenuates renal ischemia/reperfusion injury.J Transl Med. 2013 Jan 9;11:9. doi: 10.1186/1479-5876-11-9. J Transl Med. 2013. PMID: 23302512 Free PMC article.
-
Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial.Clin J Am Soc Nephrol. 2012 Sep;7(9):1498-506. doi: 10.2215/CJN.01360212. Epub 2012 Jun 28. Clin J Am Soc Nephrol. 2012. PMID: 22745272 Free PMC article. Clinical Trial.
-
PARP inhibition attenuates acute kidney allograft rejection by suppressing cell death pathways and activating PI-3K-Akt cascade.PLoS One. 2013 Dec 3;8(12):e81928. doi: 10.1371/journal.pone.0081928. eCollection 2013. PLoS One. 2013. PMID: 24312605 Free PMC article.
-
Effects of early high-dose erythropoietin on acute kidney injury following cardiac arrest: exploratory post hoc analyses from an open-label randomized trial.Clin Kidney J. 2019 Jun 17;13(3):413-420. doi: 10.1093/ckj/sfz068. eCollection 2020 Jun. Clin Kidney J. 2019. PMID: 32699621 Free PMC article.
-
Antioxidant and antiapoptotic effects of darbepoetin-α against traumatic brain injury in rats.Arch Med Sci. 2015 Oct 12;11(5):1119-28. doi: 10.5114/aoms.2015.54869. Arch Med Sci. 2015. PMID: 26528358 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical